WallStreetZenWallStreetZen

NASDAQ: CARM
Carisma Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Carisma Therapeutics earnings were -$50.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CARM earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$9.3M, down 47.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CARM reported annual earnings of -$60.5M, with -30.4% growth.

CARM earnings history

Current Revenue
$20.0M
Current Earnings
-$50.8M
Current Profit Margin
-254.3%

CARM Return on Equity

Current Company
N/A
Current Industry
-60.2%
Current Market
31.5%

CARM undefined

Current Company
-137.4%
Current Industry
-2.5%
CARM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CARM announces earnings.

CARM undefined

Current Company
-931.22%
Current Industry
5.8%
CARM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CARM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CARM-$44.47M-$50.77MN/A-$1.22
CLRB-$24.22M-$24.54MN/A-$0.55
NXTC-$46.24M-$49.52MN/A-$1.76
CGTX-$33.03M-$33.30MN/A-$0.74
LGVN-$15.80M-$25.57MN/A-$2.42
View Top Biotech Stocks

Carisma Therapeutics Earnings Reports & History FAQ

What were Carisma Therapeutics's earnings last quarter?

On CARM's earnings call on Invalid Date, Carisma Therapeutics (NASDAQ: CARM) reported Q1 2025 earnings per share (EPS) of -$0.22, up 52.17% year over year. Total CARM earnings for the quarter were -$9.27 million. In the same quarter last year, Carisma Therapeutics's earnings per share (EPS) was -$0.46.

If you're new to stock investing, here's how to buy Carisma Therapeutics stock.

Is Carisma Therapeutics profitable or losing money?

As of the last Carisma Therapeutics earnings report, Carisma Therapeutics is currently losing money. Carisma Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$50.77 million, a 37.49% decrease year over year.

What was CARM's earnings growth in the past year?

As of Carisma Therapeutics's earnings date in Invalid Date, Carisma Therapeutics's earnings has grown year over year. CARM earnings in the past year totalled -$50.77 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.